BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 21291408)

  • 1. Silica materials in drug delivery applications.
    Simovic S; Ghouchi-Eskandar N; Sinn AM; Losic D; Prestidge CA
    Curr Drug Discov Technol; 2011 Sep; 8(3):269-76. PubMed ID: 21291408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Capped mesoporous silica nanoparticles as stimuli-responsive controlled release systems for intracellular drug/gene delivery.
    Zhao Y; Vivero-Escoto JL; Slowing II; Trewyn BG; Lin VS
    Expert Opin Drug Deliv; 2010 Sep; 7(9):1013-29. PubMed ID: 20716017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemoresponsive smart mesoporous silica systems - An emerging paradigm for cancer therapy.
    Murugan B; Krishnan UM
    Int J Pharm; 2018 Dec; 553(1-2):310-326. PubMed ID: 30316004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mesoporous silica nanoparticles as controlled release drug delivery and gene transfection carriers.
    Slowing II; Vivero-Escoto JL; Wu CW; Lin VS
    Adv Drug Deliv Rev; 2008 Aug; 60(11):1278-1288. PubMed ID: 18514969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mesoporous silica nanoparticles for intracellular controlled drug delivery.
    Vivero-Escoto JL; Slowing II; Trewyn BG; Lin VS
    Small; 2010 Sep; 6(18):1952-67. PubMed ID: 20690133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functionalized mesoporous silica materials for controlled drug delivery.
    Yang P; Gai S; Lin J
    Chem Soc Rev; 2012 May; 41(9):3679-98. PubMed ID: 22441299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tailored Mesoporous Silica Nanoparticles for Controlled Drug Delivery: Platform Fabrication, Targeted Delivery, and Computational Design and Analysis.
    She X; Chen L; Yi Z; Li C; He C; Feng C; Wang T; Shigdar S; Duan W; Kong L
    Mini Rev Med Chem; 2018; 18(11):976-989. PubMed ID: 27145854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aerosol-Assisted Synthesis of Tailor-Made Hollow Mesoporous Silica Microspheres for Controlled Release of Antibacterial and Anticancer Agents.
    Poostforooshan J; Belbekhouche S; Shaban M; Alphonse V; Habert D; Bousserrhine N; Courty J; Weber AP
    ACS Appl Mater Interfaces; 2020 Feb; 12(6):6885-6898. PubMed ID: 31967774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functionalized mesoporous silica particles for application in drug delivery system.
    Pang J; Luan Y; Yang X; Jiang Y; Zhao L; Zong Y; Li Z
    Mini Rev Med Chem; 2012 Jul; 12(8):775-88. PubMed ID: 22512562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Mesoporous silica nanoparticles for cancer theranostic drug delivery].
    Wang X; Teng ZG; Huang XY; Lu GM
    Yao Xue Xue Bao; 2013 Jan; 48(1):8-13. PubMed ID: 23600135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mesoporous-Silica-Functionalized Nanoparticles for Drug Delivery.
    Giret S; Wong Chi Man M; Carcel C
    Chemistry; 2015 Sep; 21(40):13850-65. PubMed ID: 26250991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell microenvironment stimuli-responsive controlled-release delivery systems based on mesoporous silica nanoparticles.
    Zhu CL; Wang XW; Lin ZZ; Xie ZH; Wang XR
    J Food Drug Anal; 2014 Mar; 22(1):18-28. PubMed ID: 24673901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug delivery from ordered mesoporous matrices.
    Manzano M; Colilla M; Vallet-Regí M
    Expert Opin Drug Deliv; 2009 Dec; 6(12):1383-400. PubMed ID: 19941412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Controlled drug delivery systems for cancer based on mesoporous silica nanoparticles.
    Iturrioz-Rodríguez N; Correa-Duarte MA; Fanarraga ML
    Int J Nanomedicine; 2019; 14():3389-3401. PubMed ID: 31190798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mesoporous Silica Nanoparticles in Cancer Therapy: Relevance of the Targeting Function.
    Pasqua L; Leggio A; Sisci D; Andò S; Morelli C
    Mini Rev Med Chem; 2016; 16(9):743-53. PubMed ID: 26996622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Smart multifunctional drug delivery towards anticancer therapy harmonized in mesoporous nanoparticles.
    Baek S; Singh RK; Khanal D; Patel KD; Lee EJ; Leong KW; Chrzanowski W; Kim HW
    Nanoscale; 2015 Sep; 7(34):14191-216. PubMed ID: 26260245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Controlled release of silyl ether camptothecin from thiol-ene click chemistry-functionalized mesoporous silica nanoparticles.
    Yan Y; Fu J; Wang T; Lu X
    Acta Biomater; 2017 Mar; 51():471-478. PubMed ID: 28131940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Breakable mesoporous silica nanoparticles for targeted drug delivery.
    Maggini L; Cabrera I; Ruiz-Carretero A; Prasetyanto EA; Robinet E; De Cola L
    Nanoscale; 2016 Apr; 8(13):7240-7. PubMed ID: 26974603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rod-shaped mesoporous silica nanoparticles for nanomedicine: recent progress and perspectives.
    Cong VT; Gaus K; Tilley RD; Gooding JJ
    Expert Opin Drug Deliv; 2018 Sep; 15(9):881-892. PubMed ID: 30173560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advances in mesoporous silica nanoparticles for targeted stimuli-responsive drug delivery: an update.
    Castillo RR; Lozano D; González B; Manzano M; Izquierdo-Barba I; Vallet-Regí M
    Expert Opin Drug Deliv; 2019 Apr; 16(4):415-439. PubMed ID: 30897978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.